Browsing: Alzheimers
Researchers from ETH Zurich have developed an active ingredient that slows the progression of typical Alzheimer’s symptoms in mice. This…
A team led by researcher José Vicente Sánchez Mut at the Institute of Neurosciences (IN), a joint center of the…
New research highlights the ages at which Alzheimer’s-related brain changes accelerate, offering critical clues about when screening may be most…
Alzheimer’s disease is characterized by the accumulation of two proteins in the brain: amyloid-beta and tau. Tau normally stabilizes the…
Elderly people with a genetic risk for Alzheimer’s disease did not experience the expected increase in cognitive decline and dementia…
Programs matching caregivers with patient navigators yield better results than Alzheimer’s drug – but a combination of the two may…
The Alzheimer’s Global Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology,…
For more than a century, Alzheimer’s disease (AD) has been considered irreversible. Consequently, research has focused on preventing or slowing…
Alzheimer’s disease presents one of the most important health challenges we face today. With more than 55 million people worldwide…
A new study led by ICAHN School of Medicine on Mount Sinai offers one of the most comprehensive views on…